Christoph Röcken
- Oncology top 0.2%
- Peptidase Inhibition and Analysis 37
- Pancreatic and Hepatic Oncology Research 36
- Gastroenterology top 0.5%
- Cancer Research top 0.5%
- Molecular Biology top 0.5%
- Amyloidosis: Diagnosis, Treatment, Outcomes 121
- Epigenetics and DNA Methylation 21
- Nephrology top 0.5%
-
- Gastric Cancer Management and Outcomes 43
-
- Alzheimer's disease research and treatments 27
-
- Neuroendocrine Tumor Research Advances 27
-
- Genetic factors in colorectal cancer 22
- Co-authors
- Hans‐Michael BehrensAlbert RoessnerSandra KrügerMatthias EbertUwe LendeckelMatthias P. EbertPeter MalfertheinerChristine Böger
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Circulation (6 papers)Nature Medicine (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Christoph Röcken
456 papers receiving 16.9k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Oncology 5.3k
- Gastroenterology 911
- Cancer Research 2.3k
- Molecular Biology 8.2k
- Nephrology 802
Countries citing papers authored by Christoph Röcken
This map shows the geographic impact of Christoph Röcken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Röcken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Röcken more than expected).
Fields of papers citing papers by Christoph Röcken
This network shows the impact of papers produced by Christoph Röcken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Röcken. The network helps show where Christoph Röcken may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christoph Röcken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 18 | |
| 10 | 2022 | 27 | |
| 11 | 2020 | 11 | |
| 12 | 2019 | 62 | |
| 13 | 2018 | 21 | |
| 14 | 2017 | 14 | |
| 15 | 2008 | 89 | |
| 16 | 2008 | 139 | |
| 17 | 2007 | 61 | |
| 18 | Interdisziplinäre Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen: Herausgegeben von der Deutschen Gesellschaft für Amyloid-Krankheiten e. V. (www.amyloid.de) | 2006 | 0 |
| 19 | 2005 | 170 | |
| 20 | 1997 | 21 |
About Christoph Röcken
Christoph Röcken is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 474 papers that have together received 17.2k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (121 papers), Gastric Cancer Management and Outcomes (43 papers), Peptidase Inhibition and Analysis (37 papers), Pancreatic and Hepatic Oncology Research (36 papers), Alzheimer's disease research and treatments (27 papers), Neuroendocrine Tumor Research Advances (27 papers), Genetic factors in colorectal cancer (22 papers) and Epigenetics and DNA Methylation (21 papers). The work is most often cited by research in Oncology (5.3k citations), Gastroenterology (911 citations) and Cancer Research (2.3k citations). Christoph Röcken has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hans‐Michael Behrens, Albert Roessner, Sandra Krüger, Matthias Ebert, Uwe Lendeckel, Matthias P. Ebert, Peter Malfertheiner, Christine Böger, Stacy Carl-McGrath and Helmut Klein. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.